共 38 条
[1]
Cohen-Wolkowiez M(2009)Pediatric antifungal agents Curr Opin Infect Dis 22 553-558
[2]
Maan C(2008)Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes Clin Infect Dis 46 201-211
[3]
Benjamin DK(2009)Antifungal therapeutic drug monitoring: established and emerging indications Antimicrob Agents Chemother 53 23-34
[4]
Pascual A(2004)Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple dose administration Antimicrob Agents Chemother 48 2166-2172
[5]
Calandra T(2009)Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies Antimicrob Agents Chemother 53 935-944
[6]
Bolay S(2010)Voriconazole pharmacokinetics and pharmacodynamics in children Clin Infect Dis 50 27-36
[7]
Andes D(2009)Therapeutic drug monitoring of voriconazole in pediatric patients Mycoses 52 23-770
[8]
Pascual A(2009)Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation J Antimicrob Chemother 63 767-2553
[9]
Marchetti O(2002)Pharmacokinetics and safety of voriconazole following intravenous to oral dose escalation regimens Antimicrob Agents Chemother 46 2546-85
[10]
Walsh TJ(2010)In vitro hepatic metabolism explains higher clearance of voriconazoel in children versus adults: role of CYP2C19 and flavin-containing monooxygenase 3 Drug Metab Disp 38 25-44